In January 2014 the Pakistan Cricket Board (PCB) has reported an anti-doping rule violation against the cricket player Kashif Siddique after his sample tested positive for the prohibited substances 19-norandrostenedione, 19-norandrosterone (Nandrolone) and Stanozolol. After notification a provisional suspension was ordered.
The Athlete filed a statement in his defence and he was heard for the PCB Anti-Doping Tribunal.
The Athlete admitted the violation and stated that he had used the presctribed medication Wingstole and Deca Durabilin, without a TUE, as treatment for his shoulder injury as possible source of the positive test. The Athlete asserted that the violation was not intentional and that he acted with No Fault or Negligence.
The Tribunal did not accept the Athlete's statement and finds that he failed to produce evidence that the medication he used was the source of the positive test, neither that he underwent medical treatment.
The PCB Anti-Doping Tribunal concludes that the Athlete acted with negligence and without grounds for a reduced sanction it decides on 26 April 2014 to impose a 2 year period of ineligbility on the Athlete starting on the date of the provisional suspension, i.e. on 8 January 2014.
